News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
MATHIESEN JEFFREY S
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/29/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/14/2022 |
4
| MATHIESEN JEFFREY S (CFO and Treasurer) has filed a Form 4 on HELIUS MEDICAL TECHNOLOGIES, INC.|
Txns:
| Granted 18,000 options to buy
@ $0.54, valued at
$9.7k
|
|
| 08/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/18/2022 |
4
| MATHIESEN JEFFREY S (CFO and Treasurer) has filed a Form 4 on HELIUS MEDICAL TECHNOLOGIES, INC.|
Txns:
| Granted 8,011 shares
@ $0 |
|
| 12/20/2021 |
4
| MATHIESEN JEFFREY S (CFO and Treasurer) has filed a Form 4 on HELIUS MEDICAL TECHNOLOGIES, INC.|
Txns:
| Bought 3,000 shares
@ $5.3098, valued at
$15.9k
|
|
| 06/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/27/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/03/2020 |
4
| MATHIESEN JEFFREY S (Director) has filed a Form 4 on Panbela Therapeutics, Inc.|
Txns:
| Granted 2,875 shares
@ $0 |
|
| 06/26/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2020 |
4
| MATHIESEN JEFFREY S (Director) has filed a Form 4 on NEUROONE MEDICAL TECHNOLOGIES Corp|
Txns:
| Exercised 34,020 options to buy
@ $0.035, valued at
$1.2k
|
|
| 06/04/2020 |
4
| MATHIESEN JEFFREY S (Director) has filed a Form 4 on NEUROONE MEDICAL TECHNOLOGIES Corp|
Txns:
| Granted 22,371 shares
@ $0
Granted 23,725 options to buy
@ $1.48, valued at
$35.1k
|
|
| 02/11/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/07/2019 |
4
| MATHIESEN JEFFREY S (Director) has filed a Form 4 on NEUROONE MEDICAL TECHNOLOGIES Corp|
Txns:
| Granted 100,000 options to buy
@ $2.14, valued at
$214k
|
|
| 06/06/2019 |
4
| MATHIESEN JEFFREY S (Director) has filed a Form 4 on NEUROONE MEDICAL TECHNOLOGIES Corp|
Txns:
| Granted 14,006 shares
@ $0
Granted 14,995 options to buy
@ $2.38, valued at
$35.7k
|
|
| 05/23/2019 |
4
| MATHIESEN JEFFREY S (Director) has filed a Form 4 on Sun BioPharma, Inc.|
Txns:
| Granted 27,000 options to buy
@ $2.95, valued at
$79.7k
Granted 6,800 options to buy
@ $2.95, valued at
$20.1k
|
|
| 05/15/2019 |
4
| MATHIESEN JEFFREY S (Director) has filed a Form 4 on NEUROONE MEDICAL TECHNOLOGIES Corp|
Txns:
| Granted 45,605 options to buy
@ $2.38, valued at
$108.5k
|
|
| 02/22/2018 |
4
| MATHIESEN JEFFREY S (Director) has filed a Form 4 on Sun BioPharma, Inc.|
Txns:
| Bought 3,000 shares
@ $0
Bought 3,000 warrants
@ $5, valued at
$15k
|
|
| 01/30/2018 |
4
| MATHIESEN JEFFREY S (CFO) has filed a Form 4 on Gemphire Therapeutics Inc.|
Txns:
| Granted 48,000 options to buy
@ $10.1, valued at
$484.8k
|
|
| 08/16/2017 |
4
| MATHIESEN JEFFREY S (CFO) has filed a Form 4 on Gemphire Therapeutics Inc.|
Txns:
| Exercised 3,207 options to buy
@ $3.59, valued at
$11.5k
|
|
| 08/11/2017 |
4
| MATHIESEN JEFFREY S (CFO) has filed a Form 4 on Gemphire Therapeutics Inc.|
Txns:
| Exercised 3,000 options to buy
@ $3.59, valued at
$10.8k
|
|
| 12/14/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/08/2016 |
4
| MATHIESEN JEFFREY S (CFO) has filed a Form 4 on Gemphire Therapeutics Inc. |
| 09/10/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 11/14/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|